{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:09:16Z","timestamp":1793981356974,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72374049"],"award-info":[{"award-number":["72374049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72342016"],"award-info":[{"award-number":["72342016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multimorbidity is highly prevalent among individuals with diabetes and exerts a substantial impact on healthcare systems. This study aims to investigate the prevalence and healthcare costs of multimorbidity in patients with type 2 diabetes and to assess the influence of multimorbidity on healthcare expenditures using machine learning approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study utilizing chronic disease management database and health insurance claim database from a city in eastern China. Twenty-nine multimorbidities with a prevalence exceeding 1% among diabetic patients were identified using ICD codes. We analyzed the trends in prevalence and healthcare costs from 2014 to 2019. Machine learning models were developed to predict healthcare expenditures, and SHAP analysis was applied to the optimal model to evaluate the contribution of specific multimorbidity to healthcare costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 79,910 patients, the prevalence of multimorbidity increased from 87.9% in 2014 to 99.3% in 2019, while the proportion of healthcare costs attributed to multimorbidity rose from 31.8% to 34.2%. In 2019, the most prevalent conditions were hypertension (88.3%), arthritis (74.7%), and chronic ischemic heart disease (54.6%), whereas the highest-cost conditions included sequelae of cerebrovascular disease ($3,860.8), cerebral infarction ($2,768.8), and renal failure ($1,543.9). SHAP analysis revealed that cerebrovascular disease sequelae, heart failure, chronic ischemic heart disease, and chronic obstructive pulmonary disease had the most significant impact on future healthcare costs for diabetic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multimorbidity is nearly universal among individuals with diabetes in China, with cardiovascular, cerebrovascular, and chronic respiratory diseases contributing disproportionately to healthcare expenditures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13690-025-01746-6","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:14:00Z","timestamp":1762420440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of multimorbidity on healthcare costs in patients with type 2 diabetes in China: a longitudinal analysis of health insurance claims data"],"prefix":"10.1186","volume":"83","author":[{"given":"Xing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"5","key":"1746_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051770","volume":"21","author":"N Rachdaoui","year":"2020","unstructured":"Rachdaoui N. Insulin. The friend and the foe in the development of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(5):1770.","journal-title":"Int J Mol Sci"},{"issue":"10258","key":"1746_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"10397","key":"1746_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"key":"1746_CR4","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2021","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"1746_CR5","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu J, Liu M, Chai Z, et al. Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030. The Lancet Regional Health. 2023;33:100700.","journal-title":"The Lancet Regional Health"},{"key":"1746_CR6","doi-asserted-by":"crossref","unstructured":"Heikkala E, Mikkola I, Jokelainen J et al. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study. BMC Health Serv Res. 2021;21(1):964.","DOI":"10.1186\/s12913-021-06989-x"},{"key":"1746_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108053","volume":"161","author":"A Ceriello","year":"2020","unstructured":"Ceriello A, deValk HW, Guerci B, et al. The burden of type 2 diabetes in europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives. Diabetes Res Clin Pract. 2020;161:108053.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1746_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107979","volume":"26","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, He P, Yao H, et al. A network-based study reveals multimorbidity patterns in people with type 2 diabetes. iScience. 2023;26(10):107979.","journal-title":"iScience"},{"issue":"4","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/dme.12647","volume":"32","author":"ML Alva","year":"2015","unstructured":"Alva ML, Gray A, Mihaylova B, et al. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med. 2015;32(4):459\u201366.","journal-title":"Diabet Med"},{"issue":"12","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1007\/s00125-020-05277-3","volume":"63","author":"E Andersson","year":"2020","unstructured":"Andersson E, Persson S, Hall\u00e9n N, et al. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia. 2020;63(12):2582\u201394.","journal-title":"Diabetologia"},{"issue":"1","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40273-018-0699-1","volume":"37","author":"K K\u00e4hm","year":"2019","unstructured":"K\u00e4hm K, Laxy M, Schneider U, et al. Exploring different strategies of assessing the economic impact of multiple Diabetes-Associated complications and their interactions: a large claims-based study in Germany. Pharmacoeconomics. 2019;37(1):63\u201374.","journal-title":"Pharmacoeconomics"},{"issue":"740","key":"1746_CR12","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.3399\/BJGP.2023.0026","volume":"74","author":"M Soley-Bori","year":"2024","unstructured":"Soley-Bori M, Ashworth M, McGreevy A, et al. Disease patterns in high-cost individuals with multimorbidity: a retrospective cross-sectional study in primary care. Br J Gen Pract. 2024;74(740):e141\u2013148.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"1746_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14737167.2019.1661777","volume":"20","author":"X Duan","year":"2020","unstructured":"Duan X, Li Y, Liu Q, et al. Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus. Expert Rev Pharmacoecon Outcomes Res. 2020;20(5):513\u201321.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"14","key":"1746_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/atm.2019.06.08","volume":"7","author":"HDT Bui","year":"2019","unstructured":"Bui HDT, Jing X, Lu R, et al. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study. Ann Transl Med. 2019;7(14):325.","journal-title":"Ann Transl Med"},{"issue":"11","key":"1746_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020647","volume":"8","author":"H Wu","year":"2018","unstructured":"Wu H, Eggleston KN, Zhong J, et al. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China. BMJ Open. 2018;8(11):e020647.","journal-title":"BMJ Open"},{"key":"1746_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/26335565231219421","volume":"13","author":"S Walsh","year":"2023","unstructured":"Walsh S, Gillespie P. Exploring the link between multimorbidity and direct healthcare costs in Ireland: a cross-sectional study. J Multimorb Comorb. 2023;13:26335565231219421.","journal-title":"J Multimorb Comorb"},{"issue":"1","key":"1746_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-024-01113-x","volume":"22","author":"PB Tran","year":"2024","unstructured":"Tran PB, Nikolaidis GF, Abatih E, et al. Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study). Health Res Policy Syst. 2024;22(1):35.","journal-title":"Health Res Policy Syst"},{"issue":"7","key":"1746_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073693","volume":"18","author":"JH Wu","year":"2021","unstructured":"Wu JH, Wu Y, Wang ZJ. Healthcare costs associated with complications in patients with type 2 diabetes among 1.85 million adults in Beijing, China. Int J Environ Res Public Health. 2021;18(7):3693.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1746_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06989-x","volume":"21","author":"E Heikkala","year":"2021","unstructured":"Heikkala E, Mikkola I, Jokelainen J, et al. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study. BMC Health Serv Res. 2021;21(1):964.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"1746_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003094","volume":"17","author":"JI Chiang","year":"2020","unstructured":"Chiang JI, Hanlon P, Li TC, et al. Multimorbidity, mortality, and HbA1c in type 2 diabetes: a cohort study with UK and Taiwanese cohorts. PLoS Med. 2020;17(5):e1003094.","journal-title":"PLoS Med"},{"key":"1746_CR21","doi-asserted-by":"publisher","first-page":"6324348","DOI":"10.1155\/2019\/6324348","volume":"2019","author":"T Rehling","year":"2019","unstructured":"Rehling T, Bj\u00f8rkman AD, Andersen MB, et al. Diabetes is associated with musculoskeletal Pain, Osteoarthritis, Osteoporosis, and rheumatoid arthritis. J Diabetes Res. 2019;2019:6324348.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1746_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17(1):83.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1746_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101370","volume":"48","author":"V Durlach","year":"2022","unstructured":"Durlach V, Verg\u00e8s B, Al-Salameh A, et al. Smoking and diabetes interplay: a comprehensive review and joint statement. Diabetes Metab. 2022;48(6):101370.","journal-title":"Diabetes Metab"},{"issue":"7","key":"1746_CR24","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1111\/dom.16414","volume":"27","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Huang Z, Xi Y, et al. Association between adherence to the EAT-lancet diet and risk of microvascular complications in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2025;27(7):3858\u201368.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"1746_CR25","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2337\/dc23-0937","volume":"46","author":"FPB Kristensen","year":"2023","unstructured":"Kristensen FPB, Sanchez-Lastra MA, Dalene KE, et al. Leisure-time physical activity and risk of microvascular complications in individuals with type 2 diabetes: a UK biobank study. Diabetes Care. 2023;46(10):1816\u201324.","journal-title":"Diabetes Care"},{"issue":"1","key":"1746_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/brimed\/ldy013","volume":"126","author":"CJ Bailey","year":"2018","unstructured":"Bailey CJ, Day C. Treatment of type 2 diabetes: future approaches. Br Med Bull. 2018;126(1):123\u201337.","journal-title":"Br Med Bull"},{"issue":"1","key":"1746_CR27","doi-asserted-by":"publisher","first-page":"20653","DOI":"10.1038\/s41598-022-24217-2","volume":"12","author":"A la Martinez-De","year":"2022","unstructured":"la Martinez-De A, Perez-Cruz F, Weiler S, et al. Comorbidity clusters associated with newly treated type 2 diabetes mellitus: a bayesian nonparametric analysis. Sci Rep. 2022;12(1):20653.","journal-title":"Sci Rep"},{"issue":"1","key":"1746_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1373-y","volume":"17","author":"M Nowakowska","year":"2019","unstructured":"Nowakowska M, Zghebi SS, Ashcroft DM, et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. 2019;17(1):145.","journal-title":"BMC Med"},{"issue":"1","key":"1746_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13300-020-00967-y","volume":"12","author":"X He","year":"2021","unstructured":"He X, Zhang Y, Zhou Y, et al. Direct medical costs of incident complications in patients newly diagnosed with type 2 diabetes in China. Diabetes Ther. 2021;12(1):275\u201388.","journal-title":"Diabetes Ther"},{"issue":"6","key":"1746_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10198-013-0513-0","volume":"15","author":"J Le\u015bniowska","year":"2014","unstructured":"Le\u015bniowska J, Schubert A, Wojna M, et al. Costs of diabetes and its complications in Poland. Eur J Health Econ. 2014;15(6):653\u201360.","journal-title":"Eur J Health Econ"},{"issue":"2","key":"1746_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s13300-018-0548-4","volume":"10","author":"D Chapman","year":"2019","unstructured":"Chapman D, Foxcroft R, Dale-Harris L, et al. Insights for care: the healthcare utilisation and cost impact of managing type 2 diabetes-associated microvascular complications. Diabetes Ther. 2019;10(2):575\u201385.","journal-title":"Diabetes Ther"},{"issue":"2","key":"1746_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1071\/PY12035","volume":"19","author":"I McRae","year":"2013","unstructured":"McRae I, Yen L, Jeon YH, et al. Multimorbidity is associated with higher out-of-pocket spending: a study of older Australians with multiple chronic conditions. Aust J Prim Health. 2013;19(2):144\u20139.","journal-title":"Aust J Prim Health"},{"issue":"3","key":"1746_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213258","volume":"14","author":"HJ Kan","year":"2019","unstructured":"Kan HJ, Kharrazi H, Chang HY, et al. Exploring the use of machine learning for risk adjustment: a comparison of standard and penalized linear regression models in predicting health care costs in older adults. PLoS ONE. 2019;14(3):e0213258.","journal-title":"PLoS ONE"},{"issue":"6","key":"1746_CR34","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1109\/JBHI.2020.3034092","volume":"25","author":"L Luo","year":"2021","unstructured":"Luo L, Yu X, Yong Z, et al. Design comorbidity portfolios to improve treatment cost prediction of asthma using machine learning. IEEE J Biomed Health Inform. 2021;25(6):2237\u201347.","journal-title":"IEEE J Biomed Health Inform"},{"issue":"2","key":"1746_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10198-021-01363-4","volume":"23","author":"A Vimont","year":"2022","unstructured":"Vimont A, Leleu H, Durand-Zaleski I. Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France. Eur J Health Econ. 2022;23(2):211\u201323.","journal-title":"Eur J Health Econ"},{"issue":"6","key":"1746_CR36","first-page":"2247","volume":"23","author":"JL Shi","year":"2023","unstructured":"Shi JL, Wang XQ, Wang X. Modeling individual medical expenditures: from linear regression to machine learning. China Economic Q. 2023;23(6):2247\u201363. [in China].","journal-title":"China Economic Q"},{"issue":"9","key":"1746_CR37","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.37765\/ajmc.2022.89225","volume":"28","author":"P Belligund","year":"2022","unstructured":"Belligund P, Attaway A, Lopez R, et al. Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations. Am J Manag Care. 2022;28(9):e325\u201332.","journal-title":"Am J Manag Care"},{"issue":"7","key":"1746_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, et al. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881\u201390.","journal-title":"Value Health"},{"issue":"2","key":"1746_CR39","doi-asserted-by":"publisher","first-page":"E390","DOI":"10.9778\/cmajo.20210265","volume":"10","author":"J Wick","year":"2022","unstructured":"Wick J, Campbell DJT, McAlister FA, et al. Identifying subgroups of adult high-cost health care users: a retrospective analysis. CMAJ Open. 2022;10(2):E390\u20139.","journal-title":"CMAJ Open"},{"issue":"Suppl 1","key":"1746_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-018-0568-3","volume":"17","author":"C Yang","year":"2018","unstructured":"Yang C, Delcher C, Shenkman E, et al. Machine learning approaches for predicting high cost high need patient expenditures in health care. Biomed Eng Online. 2018;17(Suppl 1):131.","journal-title":"Biomed Eng Online"},{"issue":"4","key":"1746_CR41","first-page":"204","volume":"5","author":"ES So","year":"2011","unstructured":"So ES, Chin YR, Lee IS. Relationship between health-related behavioral and psychological factors and cardiovascular and cerebrovascular diseases comorbidity among Korean adults with diabetes. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(4):204\u20139.","journal-title":"Asian Nurs Res (Korean Soc Nurs Sci)"},{"issue":"1","key":"1746_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01688-3","volume":"21","author":"X He","year":"2022","unstructured":"He X, Li D, Wang W, et al. Identifying patterns of clinical conditions among high-cost older adult health care users using claims data: a latent class approach. Int J Equity Health. 2022;21(1):86.","journal-title":"Int J Equity Health"},{"issue":"1","key":"1746_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.numecd.2022.09.018","volume":"33","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Dekker LH, Mierau JO. Socio-economic gradients in diagnosed and undiagnosed type 2 diabetes and its related health complications. Nutr Metab Cardiovasc Dis. 2023;33(1):90\u20134.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1746_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84374-4","volume":"15","author":"N Kov\u00e1cs","year":"2025","unstructured":"Kov\u00e1cs N, Mahrouseh N, Monasta L, et al. The diabetes mellitus comorbidity index in European Union member states based on the 2019 European health interview survey. Sci Rep. 2025;15(1):512.","journal-title":"Sci Rep"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:10:44Z","timestamp":1762423844000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-025-01746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01746-6","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was conducted according to the guidelines of the Declaration of Helsinki and was reviewed and approved by The Ethics Review Committee of the School of Public Health, Fudan University (IRB#2023-02-261). Since the data we used came from two anonymized and secondary databases, human participants were not directly involved in the study, and the informed consent was exempted by The Ethics Review Committee of the School of Public Health, Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}